Judgment;Information — ECLI:EU:T:2023:135
Date: 2023-03-15
Language of the case: English
Court formation: Eighth Chamber
Subject matter: Trade marks;Intellectual, industrial and commercial property
Procedure: Action for annulment - unfounded

Action brought on 4 April 2022 – Novartis v EUIPO – AstraZeneca (BREZTRI) (Case T-175/22) Language in which the application was lodged: English Parties Applicant: Novartis AG (Basel, Switzerland) (represented by: A. Nordemann-Schiffel, lawyer) Defendant: European Union Intellectual Property Office (EUIPO) Other party to the proceedings before the Board of Appeal: AstraZeneca AB (Södertälje, Sweden) Details of the proceedings before EUIPO Proprietor of the trade mark at issue: Other party to the proceedings before the Board of Appeal Trade mark at issue: European Union word mark BREZTRI – European Union trade mark No 17 816 687 Procedure before EUIPO: Cancellation proceedings Contested decision: Decision of the Second Board of Appeal of EUIPO of 21 January 2022 in Case R 737/2021-2 Form of order sought The applicant claims that the Court should: annul the contested decision; order EUIPO to pay the costs. Pleas in law Infringement of Article 27(3)(b) of Commission Delegated Regulation (EU) 2017/1430; Infringement of Article 60(1)(a) in conjunction with Article 8(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council. ____________